Search

Subject Periodicals

23791. 2801 Antitumor activity and safety of pembrolizumab in patients with PD-L1-positive nasopharyngeal carcinoma: Interim results from a hase 1b study. (September 2015)

Authors:
Hsu, C.; Lee, S.H.; Ejadi, S.; Even, C.; Cohen, R.; Le Tourneau, C.; Mehnert, J.; Algazi, A.; Van Brummelen, E.; Yuan, S.S.; Thanigaimani, P.; Cheng, J.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S558
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

23792. 2802 Phase II study of first-line paclitaxel (PTX) with panitumumab (P) in patients with metastatic or recurrent head and neck cancer: TTCC-2009-03 study. (September 2015)

Authors:
Del Barco Morillo, E.; Mesia, R.; Adansa Klain, J.C.; Fernández, S. Vazquez; Galan, J. Martínez; Borgoñnon, M. Pastor; Rivas, C. González; Caballero Daroqui, J.; Berrocal, A.; Trufero, J. Martínez; Cruz Hernández, J.J.; Vera, R.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S558
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

23797. 2807 Phase II explorative trial to prospectively investigate predictive molecular biomarkers for efficacy of panitumumab (P) in platinum-pretreated head and neck squamous cell cancer (HNSCC). (September 2015)

Authors:
Siano, M.; Molinari, F.; Martin, V.; Mach, N.; Früh, M.; Meehan, B.; Crippa, S.; Ghielmini, M.; Espeli, V.; Frattini, M.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S560
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗